It has been observed that NRF-1 expression in tamoxifen-resistant BC cells was higher than sensitive BC cells, as well as endocrine-resistant phenotypes associated with a bioenergetics profile much more vulnerable to metabolic stress than endocrine sensitive BC cells. Here, NRF1 is linked to breast cancer.